Center for Scientific Review; Notice of Closed Meetings, 6645-6647 [E9-2600]

Download as PDF Federal Register / Vol. 74, No. 26 / Tuesday, February 10, 2009 / Notices arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before February 9, 2009. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by February 10, 2009. Persons attending FDA’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Christine Walsh or Denise Royster at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at https://www.fda.gov/oc/advisory/ default.htm for procedures on public conduct during advisory committee meetings. FDA regrets that it was unable to publish this notice 15 days prior to the February 18 and 19, 2009, Vaccines and Related Biological Products Advisory Committee meeting. Because the agency believes there is some urgency to bring these issues to public discussion and qualified members of the Vaccines and Related Biological Products Advisory Committee were available at this time, the Commissioner of Food and Drugs concluded that it was in the public interest to hold this meeting even if there was not sufficient time for the customary 15-day public notice. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). erowe on PROD1PC63 with NOTICES Dated: January 30, 2009. Randall W. Lutter, Deputy Commissioner for Policy. [FR Doc. E9–2726 Filed 2–5–09; 4:15 pm] BILLING CODE 4160–01–S VerDate Nov<24>2008 14:17 Feb 09, 2009 Jkt 217001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, February 12, 2009, 3 p.m. to February 12, 2009, 5 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on January 30, 2009, 74 FR 5661. The meeting will be held February 23, 2009, from 4 p.m. to 5:30 p.m. The meeting location remains the same. The meeting is closed to the public. Dated: February 2, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–2599 Filed 2–9–09; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended.The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflicts: Cognition and Hearing. Date: February 25–26, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Christine L. Melchior, PhD, Scientific Review Officer, Center for Scientific, Review National Institutes of Health, 6701 Rockledge Drive, Room 5176, MSC 7844, Bethesda, MD 20892, (301) 435– 1713, melchioc@csr.nih.gov. PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 6645 This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Ion Channels. Date: February 26, 2009. Time: 10 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: Mary Custer, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4148, MSC 7850, Bethesda, MD 20892–7850, (301) 435–1164, custerm@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflicts: Synaptic Plasticity. Date: February 26, 2009. Time: 1 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: Daniel R. Kenshalo, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5176, MSC 7844, Bethesda, MD 20892, 301–435– 1255, kenshalod@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel Small Business: Medical Imaging Date: March 3–4, 2009. Time: 8 a.m.to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bahia Resort Hotel, 998 W. Mission Bay Drive, San Diego, CA 92109. Contact Person: Leonid V. Tsap, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5128, MSC 7854, Bethesda, MD 20892, (301) 435– 2507, tsapl@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Technological Innovations for Interdisciplinary Research on Behavioral Sciences. Date: March 6, 2009. Time: 2 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance Mayflower Hotel, 1127 Connecticut Avenue, NW., Washington, DC 20036. Contact Person: Biao Tian, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3089B, MSC 7848, Bethesda, E:\FR\FM\10FEN1.SGM 10FEN1 erowe on PROD1PC63 with NOTICES 6646 Federal Register / Vol. 74, No. 26 / Tuesday, February 10, 2009 / Notices MD 20892, (301) 402–4411, tianbi@csr.nih.gov. Name of Committee: AIDS and Related Research Integrated Review Group, AIDS Molecular and Cellular Biology Study Section. Date: March 9, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bahia Resort Hotel, 998 W. Mission Bay Drive, San Diego, CA 92109. Contact Person: Kenneth A. Roebuck, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5214, MSC 7852, Bethesda, MD 20892, (301) 435– 1166, roebuckk@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Small Business: Respiratory Sciences. Date: March 9, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Ghenima Dirami, PhD, Scientific Review Officer, Center for Scientific, Review National Institutes of Health, 6701 Rockledge Drive, Room 4112, MSC 7814, Bethesda, MD 20892, 301–594– 1321, diramig@csr.nih.gov. Name of Committee: AIDS and Related Research Integrated Review Group Behavioral and Social Consequences of HIV/ AIDS Study Section. Date: March 9–10, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bahia Resort Hotel, 998 W. Mission Bay Drive, San Diego, CA 92109. Contact Person: Mark P. Rubert, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 20892, 301–435– 1775, rubertm@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, PAR–08– 105: Optimizing Technologies for the Preservation of Fertility (R21s). Date: March 9, 2009. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Stuart B. Moss, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6170, MSC 7892, Bethesda, MD 20892, 301–435– 1044, mossstua@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel Member Conflicts: Schizophrenia, Cognitive Impairment and Intervention. Date: March 10, 2009. Time: 7 a.m. to 9 p.m. Agenda: To review and evaluate grant applications. VerDate Nov<24>2008 14:17 Feb 09, 2009 Jkt 217001 Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Virtual Meeting) Contact Person: Melissa Gerald, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3172, MSC 7848, Bethesda, MD 20892, (301) 435– 0692, geraldmel@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Diabetes, Obesity and Metabolic Diseases. Date: March 10–11, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Virtual Meeting) Contact Person: Nancy Sheard, SCD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6046–E, MSC 7892, Bethesda, MD 20892, 301–435– 1154, sheardn@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Cellular and Molecular Immunology Special Emphasis Panel. Date: March 10–11, 2009. Time: 8 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Virtual Meeting) Contact Person: Patrick K. Lai, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2215, MSC 7812, Bethesda, MD 20892, 301–435– 1052, laip@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Metabolic Endocrinology 2. Date: March 10–11, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Virtual Meeting) Contact Person: Reed A. Graves, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6166, MSC 7892, Bethesda, MD 20892, (301) 402– 6297, gravesr@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Topics in Bacterial Pathogenesis. Date: March 12–13, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria, VA 22314. Contact Person: Rolf Menzel, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3196, MSC 7808, Bethesda, MD 20892, 301–435– 0952, menzelro@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, F05 Fellowship—Cell Biology. PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 Date: March 12–13, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Georgetown Suites, 1000 29th Street, NW., Washington, DC 20007. Contact Person: Alessandra M. Bini, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5142, MSC 7840, Bethesda, MD 20892, 301–435– 1024, binia@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Brain Disorders and Related Neuroscience. Date: March 12–13, 2009. Time: 8 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: One Washington Circle Hotel, One Washington Circle, Washington, DC 20037. Contact Person: George Ann McKie, DVM, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1124, MSC 7846, Bethesda, MD 20892, 301–435– 1049, mckiegeo@csr.nih.gov. Name of Committee: AIDS and Related Research Integrated Review Group, NeuroAIDS and other End-Organ Diseases Study Section. Date: March 12, 2009. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: The Fairmont Washington, DC, 2401 M Street, NW., Washington, DC 20037. Contact Person: Ranga V. Srinivas, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5216, MSC 7852, Bethesda, MD 20892, (301) 435– 1167, srinivar@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Small Business: Non-HIV Anti-Infective Therapeutics. Date: March 12–13, 2009. Time: 8:30 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Pier 5 Hotel, 711 Eastern Avenue, Baltimore, MD 21202. Contact Person: Rossana Berti, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3191, MSC 7846, Bethesda, MD 20892, 301–402– 6411, bertiros@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel Health Literacy. Date: March 12–13, 2009. Time: 6 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Delfina Santa Monica, 530 West Pico Boulevard, Santa Monica, CA 90405. Contact Person: Karen Lechter, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3128, MSC 7759, Bethesda, MD 20892, 301–496– 0726, lechterk@csr.nih.gov. E:\FR\FM\10FEN1.SGM 10FEN1 Federal Register / Vol. 74, No. 26 / Tuesday, February 10, 2009 / Notices Name of Committee: Center for Scientific Review Special Emphasis Panel, Cell Biology SBIR/STTR. Date: March 13, 2009. Time: 8 a.m. to 7 p.m. Agenda: To review and evaluate grant applications. Place: The Fairmont Washington, DC, 2401 M Street, NW., Washington, DC 20037. Contact Person: Alexandra M. Ainsztein, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5144, MSC 7840, Bethesda, MD 20892, 301–451– 3848, ainsztea@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: February 2, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–2600 Filed 2–9–09; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of Research on Women’s Health; Notice of Meeting; Moving Into the Future—New Dimensions and Strategies for Women’s Health Research for the National Institutes of Health erowe on PROD1PC63 with NOTICES Notice is hereby given that the Office of Research on Women’s Health (ORWH), Office of the Director, National Institutes of Health, Department of Health and Human Services, in collaboration with the Center for Women’s Infectious Disease Research, Washington University School of Medicine, will convene a public hearing and scientific workshop on March 4–6, 2009, at Washington University, Edward P. Newman Education Center, St. Louis, Missouri. Purpose of the Meeting With rapid advances in science and wider global understanding of women’s health and sex/gender contributions to well-being and disease, the purpose of the meeting is to ensure that NIH continues to support cutting edge women’s health research that is based upon the most advanced techniques and methodologies. The conference format will promote an interactive discussion involving leading scientists, advocacy groups, public policy experts, health care providers, and the general public. The St. Louis conference is the first in a series that will be convened VerDate Nov<24>2008 14:17 Feb 09, 2009 Jkt 217001 throughout the Nation to assist the ORWH and the NIH to move into the next decade of women’s health research. As science and technology advance and fields such as computational biology demonstrate the power of interdisciplinary research, it remains critical for sex and gender factors to be integrated into broad experimental methodologies and scientific approaches, such as genomics and the Human Microbiome Project, to maximize the value of these comprehensive and powerful approaches. Biomedical and behavioral research are also necessary to understand how cultural, ethnic, and racial differences influence the cause, diagnosis, progression, treatment, and outcome of disease among different populations, including women of diverse geographic locations and socioeconomic backgrounds. Furthermore, health disparities among diverse populations of women remain a critical area in need of continued focus and attention. The ORWH challenges all conference attendees to assist it and the NIH in defining the women’s health research agenda of the future and to think beyond traditional women’s health issues. The attendees need to identify creative strategies that are best poised for advancement, address innovative ways to approach persistent issues of health and disease, and explore new scientific concepts and investigative approaches. The attendees need to pay attention to new areas of science application, new technologies, or continuing basic science investigations. The attendees should also consider clinical questions that are not currently the focus of research priorities to ensure that women’s health research is optimally served and that the ORWH can continue to provide leadership for the benefit of women’s health, nationally and internationally. Conference Format The Conference will consist of public testimony followed by scientific panels and six concurrent workshops. Specifically, on March 4, individuals representing the full spectrum of organizations interested in biomedical and behavioral research on women’s health issues will have an opportunity to provide public testimony from 2–6 p.m. On March 5, the intersection of health care, public policy, and biomedical research will be addressed in a keynote speech designed to stimulate discussion by subsequent panels. The panels will focus on emerging issues and trends in health care that will be facing the Nation and PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 6647 on research paradigms of the future. The six concurrent afternoon sessions will focus on a range of research areas, including metagenomics/microbiome, chronic pain, urogenital disorders, the brain and neuropsychiatric disorders, urogenital infection, and obesity and eating disorders. On March 6, the morning session will be devoted to reports from the workshop co-chairs on the deliberations of the workshops. Throughout the sessions, conference attendees will be encouraged to assist the ORWH and NIH in shaping the future of women’s health research and, by extension, informing health care policy. The conference will adjourn at 1 p.m. on March 6. Public Testimony The ORWH invites individuals representing organizations with an interest in research areas related to women’s health to provide written and oral testimony on these topics and/or on issues related to women in biomedical careers. Due to time constraints, only one representative from an organization or professional specialty group will present oral testimony, with presentations limited to 5–7 minutes. Similarly, individuals not representing an organized entity but a personal point of view will have the same time constraint. A letter of intent to present such testimony should be sent electronically to https:// www.orwhmeetings.com/newdirections/ or by mail to Ms. Jory Barone, Educational Services, Inc., 4350 EastWest Highway, Suite 1100, Bethesda, MD 20814, joryb@esi-dc.com. The date of receipt of the communication will establish the order of presentations at the March meeting. Testimony should include a brief description of the organization; is limited to no more than 10 pages, double spaced, 12 point font size; and should be forwarded to the Web site listed above no later than February 20, 2009. Individuals and organizations wishing to provide written statements only should send two (2) copies of their statements, electronically or by mail, to the above Web site or address by February 20, 2009. All written testimony will be made available to the conferees prior to the March 4 meeting date. Logistics questions related to the March conference should be addressed to Ms. Jory Barone at ESI, while program-specific questions should be addressed to Dr. Jennifer Stine Elam at Washington University, 314–747–0729, elam@wustl.edu. This conference is the first of four regional public hearings and scientific E:\FR\FM\10FEN1.SGM 10FEN1

Agencies

[Federal Register Volume 74, Number 26 (Tuesday, February 10, 2009)]
[Notices]
[Pages 6645-6647]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-2600]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended.The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Member Conflicts: Cognition and Hearing.
    Date: February 25-26, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Christine L. Melchior, PhD, Scientific Review 
Officer, Center for Scientific, Review National Institutes of 
Health, 6701 Rockledge Drive, Room 5176, MSC 7844, Bethesda, MD 
20892, (301) 435-1713, melchioc@csr.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Ion Channels.
    Date: February 26, 2009.
    Time: 10 a.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892. (Telephone Conference Call)
    Contact Person: Mary Custer, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4148, MSC 7850, Bethesda, MD 20892-7850, (301) 
435-1164, custerm@csr.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Member Conflicts: Synaptic Plasticity.
    Date: February 26, 2009.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892. (Telephone Conference Call)
    Contact Person: Daniel R. Kenshalo, PhD, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5176, MSC 7844, Bethesda, MD 
20892, 301-435-1255, kenshalod@csr.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel Small Business: Medical Imaging
    Date: March 3-4, 2009.
    Time: 8 a.m.to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bahia Resort Hotel, 998 W. Mission Bay Drive, San Diego, 
CA 92109.
    Contact Person: Leonid V. Tsap, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5128, MSC 7854, Bethesda, MD 20892, (301) 435-
2507, tsapl@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Technological Innovations for Interdisciplinary Research on 
Behavioral Sciences.
    Date: March 6, 2009.
    Time: 2 p.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Renaissance Mayflower Hotel, 1127 Connecticut Avenue, 
NW., Washington, DC 20036.
    Contact Person: Biao Tian, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3089B, MSC 7848, Bethesda,

[[Page 6646]]

MD 20892, (301) 402-4411, tianbi@csr.nih.gov.

    Name of Committee: AIDS and Related Research Integrated Review 
Group, AIDS Molecular and Cellular Biology Study Section.
    Date: March 9, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bahia Resort Hotel, 998 W. Mission Bay Drive, San Diego, 
CA 92109.
    Contact Person: Kenneth A. Roebuck, PhD, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5214, MSC 7852, Bethesda, MD 
20892, (301) 435-1166, roebuckk@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Small Business: Respiratory Sciences.
    Date: March 9, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Ghenima Dirami, PhD, Scientific Review Officer, 
Center for Scientific, Review National Institutes of Health, 6701 
Rockledge Drive, Room 4112, MSC 7814, Bethesda, MD 20892, 301-594-
1321, diramig@csr.nih.gov.

    Name of Committee: AIDS and Related Research Integrated Review 
Group Behavioral and Social Consequences of HIV/AIDS Study Section.
    Date: March 9-10, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bahia Resort Hotel, 998 W. Mission Bay Drive, San Diego, 
CA 92109.
    Contact Person: Mark P. Rubert, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 20892, 301-435-
1775, rubertm@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, PAR-08-105: Optimizing Technologies for the Preservation of 
Fertility (R21s).
    Date: March 9, 2009.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Stuart B. Moss, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6170, MSC 7892, Bethesda, MD 20892, 301-435-
1044, mossstua@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel Member Conflicts: Schizophrenia, Cognitive Impairment and 
Intervention.
    Date: March 10, 2009.
    Time: 7 a.m. to 9 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892. (Virtual Meeting)
    Contact Person: Melissa Gerald, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3172, MSC 7848, Bethesda, MD 20892, (301) 435-
0692, geraldmel@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Diabetes, Obesity and Metabolic Diseases.
    Date: March 10-11, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892. (Virtual Meeting)
    Contact Person: Nancy Sheard, SCD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6046-E, MSC 7892, Bethesda, MD 20892, 301-435-
1154, sheardn@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Cellular and Molecular Immunology Special Emphasis Panel.
    Date: March 10-11, 2009.
    Time: 8 a.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892. (Virtual Meeting)
    Contact Person: Patrick K. Lai, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 2215, MSC 7812, Bethesda, MD 20892, 301-435-
1052, laip@csr.nih.gov.


    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Metabolic Endocrinology 2.
    Date: March 10-11, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892. (Virtual Meeting)
    Contact Person: Reed A. Graves, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6166, MSC 7892, Bethesda, MD 20892, (301) 402-
6297, gravesr@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Topics in Bacterial Pathogenesis.
    Date: March 12-13, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria, 
VA 22314.
    Contact Person: Rolf Menzel, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3196, MSC 7808, Bethesda, MD 20892, 301-435-
0952, menzelro@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, F05 Fellowship--Cell Biology.
    Date: March 12-13, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Georgetown Suites, 1000 29th Street, NW., Washington, DC 
20007.
    Contact Person: Alessandra M. Bini, PhD, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5142, MSC 7840, Bethesda, MD 
20892, 301-435-1024, binia@csr.nih.gov.


    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Brain Disorders and Related Neuroscience.
    Date: March 12-13, 2009.
    Time: 8 a.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: One Washington Circle Hotel, One Washington Circle, 
Washington, DC 20037.
    Contact Person: George Ann McKie, DVM, PhD, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 1124, MSC 7846, Bethesda, MD 
20892, 301-435-1049, mckiegeo@csr.nih.gov.

    Name of Committee: AIDS and Related Research Integrated Review 
Group, NeuroAIDS and other End-Organ Diseases Study Section.
    Date: March 12, 2009.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Fairmont Washington, DC, 2401 M Street, NW., 
Washington, DC 20037.
    Contact Person: Ranga V. Srinivas, PhD, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5216, MSC 7852, Bethesda, MD 
20892, (301) 435-1167, srinivar@csr.nih.gov.


    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Small Business: Non-HIV Anti-Infective Therapeutics.
    Date: March 12-13, 2009.
    Time: 8:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Pier 5 Hotel, 711 Eastern Avenue, Baltimore, MD 21202.
    Contact Person: Rossana Berti, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3191, MSC 7846, Bethesda, MD 20892, 301-402-
6411, bertiros@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel Health Literacy.
    Date: March 12-13, 2009.
    Time: 6 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Sheraton Delfina Santa Monica, 530 West Pico Boulevard, 
Santa Monica, CA 90405.
    Contact Person: Karen Lechter, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3128, MSC 7759, Bethesda, MD 20892, 301-496-
0726, lechterk@csr.nih.gov.


[[Page 6647]]


    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Cell Biology SBIR/STTR.
    Date: March 13, 2009.
    Time: 8 a.m. to 7 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Fairmont Washington, DC, 2401 M Street, NW., 
Washington, DC 20037.
    Contact Person: Alexandra M. Ainsztein, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5144, MSC 7840, Bethesda, MD 
20892, 301-451-3848, ainsztea@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: February 2, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-2600 Filed 2-9-09; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.